Dr. Kim Ma and Dr. Jean-Pierre Ayoub wrap up Day 3 of ESMO 2025 with key insights from the evERA Breast Cancer study—covering patient benefits, safety, and access—before discussing the VIKTORIA-1 results from ESMO, where Dr. Ayoub shares insights as an investigator from CHUM.
